Document is current
Any future updates will be listed below
-
Authors
Huebner, Hanna
Fasching, Peter A.
Gumbrecht, Walter
Jud, Sebastian
Rauh, Claudia
Matzas, Mark
Paulicka, Peter
Friedrich, Katja
Lux, Michael P.
Volz, Bernhard
Gass, Paul
Häberle, Lothar
Meier-Stiegen, Franziska
Hartkopf, Andreas
Neubauer, Hans
Almstedt, Katrin
Beckmann, Matthias W.
Fehm, Tanja N.
Ruebner, Matthias http://orcid.org/0000-0002-2408-1138
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EX1012B)
-
More Information
Article History
Received: 23 August 2017
Accepted: 9 February 2018
First Online: 20 February 2018
Ethics approval and consent to participate
: The study was approved by the ethics committee of the Medical Faculty, Friedrich-Alexander University Erlangen-Nuremberg and complies with the current laws of the country in which it was performed. A written informed consent was obtained from all patients. This consent included the approval of biomaterial collection and analysis as well as the access of patient/clinical data and storage in a database.
: Not applicable
: PAF received honoraria from Novartis, Pfizer, Roche, Celgene and his institution conducts research with research grant from Novartis. MPL received honoraria from Novartis, Pfizer, AstraZeneca, Roche, Celgene and his institution conducts research with research grant from Novartis. CR received honoraria from Novartis and Roche and her institution conducts research with research grant from Novartis. PG has received honoraria from Novartis. WG, MM and PP are employees of Siemens Healthcare GmbH. All other authors declare that they do not have any conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
